Abiopharma

Top Ships Announces Filing of 2025 Annual Report on Form 20-F

Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)

New Form DEFA14A - AXIS CAPITAL HOLDINGS LTD <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001214816-26-000146 <b>Size:</b> 434 KB

New Form DEF 14A - Privia Health Group, Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-138997 <b>Size:</b> 7 MB

New Form DEFM14A - MARINE PRODUCTS CORP <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-138991 <b>Size:</b> 3 MB

Transaction in Own Shares

Smith+Nephew PLC Notification

New Form ARS - WESTLAKE CORP <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-138979 <b>Size:</b> 1 MB

New Form DEFA14A - WESTLAKE CORP <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-138977 <b>Size:</b> 750 KB

General Announcement: Next Day Disclosure Return

New Form PRE 14A - Net Lease Office Properties <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001952976-26-000018 <b>Size:</b> 15 MB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Yeah Lee Ching

New Form DEFA14A - NCS Multistage Holdings, Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001437749-26-010963 <b>Size:</b> 405 KB

New Form 424B3 - MasterCraft Boat Holdings, Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-138975 <b>Size:</b> 3 MB